Related Experiment Videos
MIB1 and p53 immunoreactivity in protoplasmic astrocytomas
1Department of Anatomic Pathology, Cleveland Clinic Foundation, Ohio 44195, USA.
Pathology International
|November 1, 1996
Summary
Pure protoplasmic astrocytomas exhibit low cell proliferation, indicated by MIB1 indices. A minority of these low-grade brain tumors show p53 protein expression, suggesting a slow-growing nature.
Area of Science:
- Neuro-oncology
- Pathology
Background:
- Pure protoplasmic astrocytomas are rare, low-grade astrocytic neoplasms.
- Limited research exists specifically on this tumor subset.
Purpose of the Study:
- To investigate MIB1 (cell proliferation marker) and p53 (tumor suppressor gene) immunoreactivity in pure protoplasmic astrocytomas.
- To correlate these markers with the clinical behavior of these rare tumors.
Main Methods:
- Retrospective analysis of 18 pure protoplasmic astrocytomas.
- Immunohistochemical assessment of MIB1 and p53 expression.
- Correlation with clinical presentation, tumor location, and patient outcomes.
Main Results:
- Low MIB1 indices (mean 0.7) observed in most tumors, indicating slow proliferation.
- p53 immunoreactivity detected in 28% of the astrocytomas.
- Tumors typically presented with seizures and were located in the temporal or frontal lobes.
Conclusions:
- Low MIB1 indices support the clinical impression of slow tumor growth.
- p53 expression is infrequent in pure protoplasmic astrocytomas.
- These findings contribute to understanding the biological behavior of this rare neoplasm.